(Q44883219)

7 December 2017

title

An economic evaluation of universal vaccination against hepatitis B virus (English)

1 reference

7 December 2017

1 reference

A. McGuire

3

0 references

author name string

P Fenn

series ordinal

1

1 reference

7 December 2017

A Gray

series ordinal

2

1 reference

7 December 2017

publication date

1 May 1996

1 reference

7 December 2017

1 reference

7 December 2017

volume

32

1 reference

7 December 2017

issue

3

1 reference

7 December 2017

page(s)

197-204

1 reference

Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis.

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980019-3

7 January 2021

A reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980019-3

7 January 2021

The Markov process in medical prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980019-3

7 January 2021

Chronic type B hepatitis and the "healthy" HBsAg carrier state

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980019-3

7 January 2021

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980019-3

7 January 2021

Survival in chronic hepatitis B. An analysis of 379 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980019-3

7 January 2021

On what basis should health be discounted?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980019-3

7 January 2021

10.1016/S0163-4453(96)80019-3

Identifiers

DOI

1 reference

7 December 2017

1 reference